For decades, cancer patients have been told that shrinking tumors meant accepting brutal side effects as the price of ...

Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical Officer, effective January 2, 2026. Dr.

On Sept. 1, Gilead struck a development deal for an immuno-oncology asset—the value of which spoke volumes about the industry’s enthusiasm for emerging immune targets for treating cancer. Gilead paid ...

Immunotherapy innovation is saving the lives of cancer patients across the country, while researchers continue to break new ground in this growing oncology field. When Sameek Roychowdhury, MD, PhD, ...

Patient navigation is immensely helpful in relieving some of the burden placed on cancer patients, and there are some particularly unique aspects of navigation as it pertains to immuno-oncology. is ...

MIRAMAR, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO), a subsidiary of Generex Biotechnology Corporation (www.gen erex.com) (OTCQB:GNBT ...

This event is now apart of the Cancer Research & Immuno-Oncology Week Virtual Event Series. Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on ...

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering. The global immuno-oncology market size was estimated to be USD ...

Can you please give a brief history of immuno-oncology? Frederic Triebel: Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology ...

With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs–and across the industry many of them will be doing the same work, on the ...